FDA: Chantix (varenicline) May Increase Cardiovascular Risk
The U.S. Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix ( varenicline ) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.
Extinguishing Tobacco Deaths Around the World
Did you know that tobacco will kill 6 million people around the world this year? And by 2030, that number will be 8 million. The World Health Organization (WHO) is leading the fight against this epidemic.